Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Procopio

Showing results (101-110 of 289) with videos related to

Pageof 29
Sort By:
European Urology|January 30, 2013
Predictors of health-related quality of life and adjustment to prostate cancer during active surveillanceLara Bellardita, Tiziana Rancati, Maria Francesca Alvisi, et al.
Cancer Management and Research|October 24, 2022
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following NephrectomyAchille Bottiglieri, Pierangela Sepe, Marco Stellato, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2006
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?Emilio Bajetta, Laura Catena, Giuseppe Procopio, et al.
Tumori|December 2, 2017
TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discoveryElena Verzoni, Raffaele Ratta, Paolo Grassi, et al.
Cancer Treatment Reviews|February 23, 2023
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectivesAlfredo Berruti, Sergio Bracarda, Orazio Caffo, et al.
Expert Review of Anticancer Therapy|June 5, 2019
The role of metastasectomy in advanced renal cell carcinomaGiulia Apollonio, Alessandra Raimondi, Elena Verzoni, et al.
Current Oncology Reports|January 29, 2020
Current Understanding of Urachal Adenocarcinoma and Management StrategyMélanie Claps, Marco Stellato, Emma Zattarin, et al.
Tumori|March 15, 2005
Treatment options in hormone-refractory metastatic prostate carcinomaAlberto Fusi, Giuseppe Procopio, Silvia Della Torre, et al.
Cancers|July 2, 2021
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct CarcinomaChiara Gargiuli, Pierangela Sepe, Anna Tessari, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Pageof 29

Showing results (101-110 of 289) with videos related to

Sort By:
Pageof 29
European Urology|January 30, 2013
Predictors of health-related quality of life and adjustment to prostate cancer during active surveillanceLara Bellardita, Tiziana Rancati, Maria Francesca Alvisi, et al.
Cancer Management and Research|October 24, 2022
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following NephrectomyAchille Bottiglieri, Pierangela Sepe, Marco Stellato, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2006
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?Emilio Bajetta, Laura Catena, Giuseppe Procopio, et al.
Tumori|December 2, 2017
TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discoveryElena Verzoni, Raffaele Ratta, Paolo Grassi, et al.
Cancer Treatment Reviews|February 23, 2023
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectivesAlfredo Berruti, Sergio Bracarda, Orazio Caffo, et al.
Expert Review of Anticancer Therapy|June 5, 2019
The role of metastasectomy in advanced renal cell carcinomaGiulia Apollonio, Alessandra Raimondi, Elena Verzoni, et al.
Current Oncology Reports|January 29, 2020
Current Understanding of Urachal Adenocarcinoma and Management StrategyMélanie Claps, Marco Stellato, Emma Zattarin, et al.
Tumori|March 15, 2005
Treatment options in hormone-refractory metastatic prostate carcinomaAlberto Fusi, Giuseppe Procopio, Silvia Della Torre, et al.
Cancers|July 2, 2021
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct CarcinomaChiara Gargiuli, Pierangela Sepe, Anna Tessari, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Pageof 29